Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.
Caroline FochArthur AllignolUlrike Hostalek-GottwaldEmmanuelle BoutmyThilo HohenbergerPublished in: International journal of clinical practice (2022)
These data add to the limited pool of evidence from real-world studies exploring the effectiveness of beta-blockers versus other antihypertensive classes. Discrepancies to previously published studies might be partly explained by differences in the selected populations and in the follow-up time.
Keyphrases
- cardiovascular events
- randomized controlled trial
- coronary artery disease
- systematic review
- angiotensin converting enzyme
- cardiovascular disease
- case control
- blood pressure
- electronic health record
- type diabetes
- machine learning
- angiotensin ii
- data analysis
- genetic diversity
- deep learning
- meta analyses
- artificial intelligence